Table 2.
Clinical Outcomes in Terms of Disease Severity and Prognosis
| Disease Severity | Moderate | Severe | Critical |
|---|---|---|---|
| Hospitalization (days) | 14.60 ± 7.57 (Median: 12) | 18.11 ± 8.20 (Median: 16) | 33.26 ± 17.38 (Median: 28) |
| ICU length (days) | 0.24 ± 1.20 (Median: 0) (1pt) | 1.34 ± 5.72 (Median: 0) (6pt) | 25.07 ± 23.64 (Median: 12) (25pt) |
| Oxygen inhalation (days) | 13.08 ± 8.10 (Median: 10) | 16.64 ± 8.03 (Median: 15) | 32.93 ± 17.62 (Median: 28) |
| Sputum NAT-positive (days) | 9.56 ± 7.56 (Median: 8) | 10.89 ± 7.88 (Median: 9) | 13.70 ± 6.60 (Median: 13) |
| Prognosis (category) | 1.92 ± 0.28 (Median: 2) | 2.00 ± 0.21 (Median: 2) | 2.59 ± 0.57 (Median: 3) |
| (Prognosis, Complete Recovery, Partial Recovery, Prolonged Recovery) | |||
| Hospitalization (days) | 14.7 ± 2.3 (Median: 16) | 16.7 ± 7.3 (Median: 15) | 46.6 ± 12.1 (Median: 50) |
| ICU length (days) | 0.0 ± 0.0 (Median: 0) | 1.0 ± 2.3 (Median: 0) | 42.3 ± 18.6 (Median:49) |
| Oxygen inhalation (days) | 13.7 ± 2.5 (Median: 14) | 15.4 ± 7.3 (Median: 15) | 46.4 ± 12.4 (Median: 50) |
| Sputum NAT-positive (days) | 8.7 ± 3.2 (Median: 10) | 10.4 ± 7.6 (Median: 8) | 15.8 ± 4.6 (Median: 17) |
As per disease severity, 99 patients were categorized into three groups: moderate (n = 25), severe (n = 47), and critical (n = 27), respectively. As per prognosis, patients were categorized into 1: complete recovery (n = 3), 2: partial recovery with residual pulmonary damage (n = 80), 3: prolonged recovery (n = 15), and 4: death (n = 1).